1Collins AT, Zhiming B, Gilmore K, et al. Androgen and oestrogen -responsiveness of stremal cells derived from the human hyperplastic prostate: oestrogen regulation of the androgen receptor. J Endocrine 1994;143:362.
4Jacobsen S J,Girman C J,Guess HA,et al.Natural history of prostatism:longitudinal changes in voiding symptoms in community dwelling men[J].J Urol,1996,155:595～600
5Chatelain Ch.,Denis L.,Foo J.K.T.,et al.Recommendations of the International Scientific Committee:evaluation and treatment of lower urinary tract symptoms (LUTS) in older men[A].In:Proceedings of the Fifth International Consultation on Benign Prostatic Hyperplasia[M].United Kingdom:Health Publications,Ltd.,2001.519 ～534
6Tatemichi S, Akiyama K, Kobayashi M, et al. A selectivealphalA-adrenoceptor antagonist inhibits detrusor overactivity in a rat model of benign prostatic hyperplasia. J Urol 2006; 176(3): 1236-1241
7Gallardo Arrieta F, Mogas T, Magan L, et al. Ultrastructural changes in prostate cells during hormone-induced canine prostatic hyperplasia. Ultrastruct Pathol 2006; 30(6): 435-442
8Wang Y, Shao JC, Zhang SW. Histomorphological studies on hyperplastic prostate of castrated rat caused by androgen. Zhonghua Nan Ke Xue 2002; 8(3): 190-193
9Sumana Chakrovarty, Shashi Wadhwa, Manish Diwanl, et al.Transient compensatory hypertrophy and limited regeneration of the surgically removed rat ventral prostate. Zhonghua Nan Ke Xue 2003; 9(6): 407-412
10Ozden C, Ozdal OL, Urgancioglu G, et al. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia. Eur Urol 2007; 51(1): 199-203
